Literature DB >> 16848401

"SMART" drug delivery systems: double-targeted pH-responsive pharmaceutical nanocarriers.

R M Sawant1, J P Hurley, S Salmaso, A Kale, E Tolcheva, T S Levchenko, V P Torchilin.   

Abstract

To develop targeted pharmaceutical carriers additionally capable of responding to certain local stimuli, such as decreased pH values in tumors or infarcts, targeted long-circulating PEGylated liposomes and PEG-phosphatidylethanolamine (PEG-PE)-based micelles have been prepared with several functions. First, they are capable of targeting a specific cell or organ by attaching the monoclonal antimyosin antibody 2G4 to their surface via pNP-PEG-PE moieties. Second, these liposomes and micelles were additionally modified with biotin or TAT peptide (TATp) moieties attached to the surface of the nanocarrier by using biotin-PE or TATp-PE or TATp-short PEG-PE derivatives. PEG-PE used for liposome surface modification or for micelle preparation was made degradable by inserting the pH-sensitive hydrazone bond between PEG and PE (PEG-Hz-PE). Under normal pH values, biotin and TATp functions on the surface of nanocarriers were "shielded" by long protecting PEG chains (pH-degradable PEG(2000)-PE or PEG(5000)-PE) or by even longer pNP-PEG-PE moieties used to attach antibodies to the nanocarrier (non-pH-degradable PEG(3400)-PE or PEG(5000)-PE). At pH 7.4-8.0, both liposomes and micelles demonstrated high specific binding with 2G4 antibody substrate, myosin, but very limited binding on an avidin column (biotin-containing nanocarriers) or internalization by NIH/3T3 or U-87 cells (TATp-containing nanocarriers). However, upon brief incubation (15-30 min) at lower pH values (pH 5.0-6.0), nanocarriers lost their protective PEG shell because of acidic hydrolysis of PEG-Hz-PE and acquired the ability to become strongly retained on an avidin column (biotin-containing nanocarriers) or effectively internalized by cells via TATp moieties (TATp-containing nanocarriers). We consider this result as the first step in the development of multifunctional stimuli-sensitive pharmaceutical nanocarriers.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16848401      PMCID: PMC2538444          DOI: 10.1021/bc060080h

Source DB:  PubMed          Journal:  Bioconjug Chem        ISSN: 1043-1802            Impact factor:   4.774


  33 in total

1.  Intracellular delivery of a Tat-eGFP fusion protein into muscle cells.

Authors:  N J Caron; Y Torrente; G Camirand; M Bujold; P Chapdelaine; K Leriche; N Bresolin; J P Tremblay
Journal:  Mol Ther       Date:  2001-03       Impact factor: 11.454

2.  TAT peptide on the surface of liposomes affords their efficient intracellular delivery even at low temperature and in the presence of metabolic inhibitors.

Authors:  V P Torchilin; R Rammohan; V Weissig; T S Levchenko
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-03       Impact factor: 11.205

3.  Differential conjugation of tat peptide to superparamagnetic nanoparticles and its effect on cellular uptake.

Authors:  Ming Zhao; Moritz F Kircher; Lee Josephson; Ralph Weissleder
Journal:  Bioconjug Chem       Date:  2002 Jul-Aug       Impact factor: 4.774

Review 4.  Lipid-core micelles for targeted drug delivery.

Authors:  Vladimir P Torchilin
Journal:  Curr Drug Deliv       Date:  2005-10       Impact factor: 2.565

5.  Efficiency of protein transduction is cell type-dependent and is enhanced by dextran sulfate.

Authors:  Jeffrey C Mai; Hongmei Shen; Simon C Watkins; Tao Cheng; Paul D Robbins
Journal:  J Biol Chem       Date:  2002-05-28       Impact factor: 5.157

6.  Polyethylene glycol-diacyllipid micelles demonstrate increased acculumation in subcutaneous tumors in mice.

Authors:  Anatoly N Lukyanov; Zhonggao Gao; Laureen Mazzola; Vladimir P Torchilin
Journal:  Pharm Res       Date:  2002-10       Impact factor: 4.200

7.  Soluble biodegradable polymer-based cytokine gene delivery for cancer treatment.

Authors:  A Maheshwari; R I Mahato; J McGregor; S o Han; W E Samlowski; J S Park; S W Kim
Journal:  Mol Ther       Date:  2000-08       Impact factor: 11.454

Review 8.  Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review.

Authors:  H Maeda; J Wu; T Sawa; Y Matsumura; K Hori
Journal:  J Control Release       Date:  2000-03-01       Impact factor: 9.776

9.  p-Nitrophenylcarbonyl-PEG-PE-liposomes: fast and simple attachment of specific ligands, including monoclonal antibodies, to distal ends of PEG chains via p-nitrophenylcarbonyl groups.

Authors:  V P Torchilin; T S Levchenko; A N Lukyanov; B A Khaw; A L Klibanov; R Rammohan; G P Samokhin; K R Whiteman
Journal:  Biochim Biophys Acta       Date:  2001-04-02

10.  Cell transfection in vitro and in vivo with nontoxic TAT peptide-liposome-DNA complexes.

Authors:  Vladimir P Torchilin; Tatyana S Levchenko; Ram Rammohan; Natalia Volodina; Brigitte Papahadjopoulos-Sternberg; Gerard G M D'Souza
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-05       Impact factor: 11.205

View more
  110 in total

1.  Enhanced affinity bifunctional bisphosphonates for targeted delivery of therapeutic agents to bone.

Authors:  Jivan N Yewle; David A Puleo; Leonidas G Bachas
Journal:  Bioconjug Chem       Date:  2011-12-05       Impact factor: 4.774

Review 2.  Cancer nanomedicines targeting tumor extracellular pH.

Authors:  Li Tian; You Han Bae
Journal:  Colloids Surf B Biointerfaces       Date:  2011-10-25       Impact factor: 5.268

3.  The effect of sedimentation and diffusion on cellular uptake of gold nanoparticles.

Authors:  Eun Chul Cho; Qiang Zhang; Younan Xia
Journal:  Nat Nanotechnol       Date:  2011-04-24       Impact factor: 39.213

4.  Matrix metalloprotease 2-responsive multifunctional liposomal nanocarrier for enhanced tumor targeting.

Authors:  Lin Zhu; Pooja Kate; Vladimir P Torchilin
Journal:  ACS Nano       Date:  2012-03-14       Impact factor: 15.881

Review 5.  The use of therapeutic peptides to target and to kill cancer cells.

Authors:  R J Boohaker; M W Lee; P Vishnubhotla; J M Perez; A R Khaled
Journal:  Curr Med Chem       Date:  2012       Impact factor: 4.530

6.  Fine-tuning the pH trigger of self-assembly.

Authors:  Arijit Ghosh; Mark Haverick; Keith Stump; Xiangyu Yang; Michael F Tweedle; Joshua E Goldberger
Journal:  J Am Chem Soc       Date:  2012-02-13       Impact factor: 15.419

7.  Enhanced transfection of tumor cells in vivo using "Smart" pH-sensitive TAT-modified pegylated liposomes.

Authors:  Amit A Kale; Vladimir P Torchilin
Journal:  J Drug Target       Date:  2007 Aug-Sep       Impact factor: 5.121

8.  Quantitative analysis of the fate of gold nanocages in vitro and in vivo after uptake by U87-MG tumor cells.

Authors:  Eun Chul Cho; Yu Zhang; Xin Cai; Christine M Moran; Lihong V Wang; Younan Xia
Journal:  Angew Chem Int Ed Engl       Date:  2012-12-06       Impact factor: 15.336

9.  TAT peptide and its conjugates: proteolytic stability.

Authors:  Jacob Grunwald; Tomas Rejtar; Rupa Sawant; Zhouxi Wang; Vladimir P Torchilin
Journal:  Bioconjug Chem       Date:  2009-07-14       Impact factor: 4.774

10.  Release of liposomal contents by cell-secreted matrix metalloproteinase-9.

Authors:  Jayati Banerjee; Andrea J Hanson; Bhushan Gadam; Adekunle I Elegbede; Shakila Tobwala; Bratati Ganguly; Anil V Wagh; Wallace W Muhonen; Benedict Law; John B Shabb; D K Srivastava; Sanku Mallik
Journal:  Bioconjug Chem       Date:  2009-07       Impact factor: 4.774

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.